COMMUNIQUÉS West-GlobeNewswire

Santhera Raises up to CHF 22.1 Million by Placement of Shares and Credit Line
04/04/2019
Pratteln, Switzerland, April 4, 2019 - Santhera Pharmaceuticals (SIX: SANN) announces that it has placed all of the remaining 500,000 registered shares from its existing authorized share capital in a private placement, [...]
SuperSonic Imagine will present its Aixplorer® MACH 30 ultrasound system at the American Institute of Ultrasound in Medicine (AIUM) annual convention from 6 to 10 April in Orlando, Florida, United States
04/04/2019
AIX-EN-PROVENCE, France, April 04, 2019 (GLOBE NEWSWIRE) -- SuperSonic Imagine (Euronext: SSI, FR0010526814,), a company specialising in ultrasound medical imaging (diagnostic ultrasound), will introduce Aixplorer MACH [...]
Segra Receives “Confirmation of Readiness” from Health Canada for Plant Tissue Culture Production Facility
04/04/2019
VANCOUVER, British Columbia, April 04, 2019 (GLOBE NEWSWIRE) -- Segra International Corp. (“ Segra ” or the “ Company ”), a cannabis agriculture technology company, is pleased to announce that its application for [...]
Minutes of Ordinary General Meeting
04/04/2019
REFERAT AF ORDINÆR GENERALFORSAMLING MINUTES OF ORDINARY GENERAL MEETING PROTOKOLL FRÅN ÅRSSTÄMMA Der blev afholdt ordinær generalforsamling i Oncology Venture A/S (“ Selskabet “) 4. april 2019, kl. 16.00 i Søhuset, [...]
Nanobiotix Announces First Ever Radioenhancer to Receive European Market Approval
04/04/2019
NANOBIOTIX ANNOUNCES FIRST EVER RADIOENHANCER TO RECEIVE EUROPEAN MARKET APPROVAL Hensify®(NBTXR3) received European market approval (CE mark) enabling commercialization in 27 European Union countries for the treatment [...]
NANOBIOTIX ANNONCE LA TOUTE PREMIERE AUTORISATION DE MISE SUR LE MARCHÉ EUROPEEN D’UN RADIOENHANCER
04/04/2019
NANOBIOTIX ANNONCE LA TOUTE PREMIERE AUTORISATION DE MISE SUR LE MARCH É EUROPEEN D’UN RADIOENHANCER Hensify®(NBTXR3) a reçu une autorisation de mise sur le marché (Marquage CE) en Europe permettant sa commercialisation [...]
Extraordinary General Meeting of Active Biotech AB
04/04/2019
PRESS RELEASE Lund Sweden, April 4 2019 - Active Biotech (NASDAQ STOCKHOLM: ACTI) Extraordinary General Meeting of Active Biotech An Extraordinary General Meeting of Active Biotech AB (publ) was held on April 4, 2019. [...]
Spineway : Report on the General Shareholders’ Meeting April 4th 2019
04/04/2019
Report on the General Shareholders’ Meeting Spineway, specialist in surgical implants and instruments for treating disorders of the spinal column (spine), held an Ordinary and Extraordinary General Shareholders’ Meeting [...]
SPINEWAY : Compte-rendu de l’Assemblée Générale du 4 avril 2019
04/04/2019
Compte-rendu de l’Assemblée Générale L’Assemblée Générale Mixte des actionnaires de Spineway, spécialiste des implants et ancillaires chirurgicaux pour le traitement des pathologies de la colonne vertébrale (rachis), [...]
Zealand Pharma’s Annual General Meeting in 2019
04/04/2019
Company announcement – No. 10 / 2019 Zealand Pharma’s Annual General Meeting in 2019 Copenhagen, April 4, 2019 - Today, Zealand Pharma A/S (Zealand) (CVR-no. 20 04 50 78) held its Annual General Meeting in 2019 at the [...]
Nicox: Number of Voting Rights as of March 31, 2019
04/04/2019
Nicox SA Société anonyme with a registered capital of € 29,909,120 Head Office: DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 On April 4, 2019, MONTHLY PUBLICATION OF THE [...]
NICOX: Nombre de Droits de Vote au 31 mars 2019
04/04/2019
Nicox SA Société anonyme au capital de 29 909 120 euros Siège social : DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 Le 4 avril 2019, PUBLICATION MENSUELLE DU NOMBRE D’ [...]
Council of JSC Olainfarm: JSC Olainfarm Board Members have made gross violations of authority; changes made in the Board
04/04/2019
Today, on April 4th, JSC Olainfarm Council held a meeting, in which, after hearing members of the Board and finding out gross violations of authority and failure to perform their duties, it made a decision to make [...]
Novozymes and BioAg: Continuation with Bayer as core partner; new, broader setup allows Novozymes to bring biological solutions to the market together with more partners
04/04/2019
Read the full announcement in PDF Attachment 2019_06_Future_BioAg_Setup_EN
AXIM® Biotechnologies, Inc. Appoints Mauricio Javier Gatto-Bellora to Company’s Board of Directors
04/04/2019
NEW YORK, April 04, 2019 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (“AXIM”) (“the Company”) (“AXIM ® Biotech”) (OTC:AXIM), a world leader in cannabinoid research and development, today announced the appointment of [...]
Tauriga Sciences Inc. Showcases its Graphic Design and Artwork for the Retail Display Boxes of its Two Newest Tauri-Gum Flavors: Blood Orange & Pomegranate
04/04/2019
New York, NY, April 04, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, [...]
iCAD to Highlight ProFound AI™ Solution for Digital Breast Tomosynthesis at 2019 Society of Breast Imaging Annual Symposium
04/04/2019
Company’s Latest, Deep-Learning, Cancer Detection Software Solution Recently Launched in U.S. NASHUA, N.H., April 04, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing [...]
Changes to the Management Board of JSC Olainfarm and Representation Rights
04/04/2019
JSC Olainfarm hereby informs about the following decisions taken by its Supervisory Council on April 04, 2019: Recall Olegs Grigorjevs, Mihails Raizbergs, Vladimirs Krušinskis from the position of the Management Board [...]
Terveystalo Plc: Resolutions of the Organizing Meeting of Board of Directors
04/04/2019
Terveystalo Plc, Stock Exchange Release 4 April 2019 at 17:25 EEST At its organizing meeting held after the Annual General Meeting held today, the Board of Directors of Terveystalo Plc made the following resolutions: [...]

Pages